Indeed, following PLCβ1 silencing, it is also shown in our data, an increased activation of Stat3 pathway, which is a well-defined oncogenic transcription factor that plays a key role in tumor resistance and aggressive cancer progression in glioblastoma [57]. The gene discussed is PLCB1; the disease is cancer.